Skip to main content
Premium Trial:

Request an Annual Quote

Brotman Baty Institute for Precision Medicine Launched With $50M Funding

NEW YORK (GenomeWeb) – The University of Washington School of Medicine today announced the launch of the Brotman Baty Institute for Precision Medicine (BBI), which is being funded with a $50 million gift from friends and family of recently deceased Costco Cofounder Jeff Brotman.

The BBI, which will be directed by UW Medicine's Jay Shendure, will establish a network of research labs across UW Medicine, the Fred Hutchinson Cancer Research Center, and Seattle Children's Hospital. Among the institute's first initiatives will be to catalog the roughly 60,000 estimated possible mutations of the BRCA1 and BRCA2 genes in order to identify those that confer the greatest risk of breast cancer and help patients make informed decisions about their health.

"A typical patient doesn't really exist, yet for more than a century, medicine has been focused on diagnosing and treating typical patients," Shendure said in a statement. "Precision medicine aims to use an individual patient's unique genetic code to more effectively diagnose and individually treat that person. Through both basic science and the translation of new advances to the clinic, the institute will accelerate this process."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.